7th Genome Editing Therapeutics Summit 2026

28th September 2026 - September 30, 2026

The 7th Genome Editing Therapeutics Summit returns to Boston this September as the only industry-focused meeting dedicated to applying breakthrough genome editing tools directly to the therapeutic setting.

Join R&D, preclinical, translational, regulatory, and c-suite leaders to answer one question: how do we maximize the application of genome editing therapies to patients who need them most?

Don’t miss out on insights from AbbVie, Bristol Myers Squibb, Intellia Therapeutics, Beam Therapeutics, Sanofi, and others on how genome editing can move from a promising therapy to an essential one for patients facing the most genetically complex diseases.

Event Dates: September 28-30, 2026

Event Location: Boston, MA

More Info